590 related articles for article (PubMed ID: 23537454)
41. Targeting the extracellular matrix: matricellular proteins regulate cell-extracellular matrix communication within distinct niches of the intervertebral disc.
Bedore J; Leask A; Séguin CA
Matrix Biol; 2014 Jul; 37():124-30. PubMed ID: 24874179
[TBL] [Abstract][Full Text] [Related]
42. Intervertebral disc disease in dogs - part 2: comparison of clinical, magnetic resonance imaging, and histological findings in 74 surgically treated dogs.
Kranenburg HJ; Grinwis GC; Bergknut N; Gahrmann N; Voorhout G; Hazewinkel HA; Meij BP
Vet J; 2013 Feb; 195(2):164-71. PubMed ID: 22795604
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc.
Teixeira GQ; Leite Pereira C; Castro F; Ferreira JR; Gomez-Lazaro M; Aguiar P; Barbosa MA; Neidlinger-Wilke C; Goncalves RM
Acta Biomater; 2016 Sep; 42():168-179. PubMed ID: 27321188
[TBL] [Abstract][Full Text] [Related]
44. Vascularization and morphological changes of the endplate after axial compression and distraction of the intervertebral disc.
Hee HT; Chuah YJ; Tan BH; Setiobudi T; Wong HK
Spine (Phila Pa 1976); 2011 Apr; 36(7):505-11. PubMed ID: 20975621
[TBL] [Abstract][Full Text] [Related]
45. Age-related reduction in the expression of FOXO transcription factors and correlations with intervertebral disc degeneration.
Alvarez-Garcia O; Matsuzaki T; Olmer M; Masuda K; Lotz MK
J Orthop Res; 2017 Dec; 35(12):2682-2691. PubMed ID: 28430387
[TBL] [Abstract][Full Text] [Related]
46. The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc.
Erwin WM; DeSouza L; Funabashi M; Kawchuk G; Karim MZ; Kim S; Mӓdler S; Matta A; Wang X; Mehrkens KA
Arthritis Res Ther; 2015 Sep; 17(1):240. PubMed ID: 26341258
[TBL] [Abstract][Full Text] [Related]
47. Biological and biomechanical effects of fibrin injection into porcine intervertebral discs.
Buser Z; Kuelling F; Liu J; Liebenberg E; Thorne KJ; Coughlin D; Lotz JC
Spine (Phila Pa 1976); 2011 Aug; 36(18):E1201-9. PubMed ID: 21325992
[TBL] [Abstract][Full Text] [Related]
48. Macrophages and Intervertebral Disc Degeneration.
Koroth J; Buko EO; Abbott R; Johnson CP; Ogle BM; Stone LS; Ellingson AM; Bradley EW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674887
[TBL] [Abstract][Full Text] [Related]
49. Molecular basis of intervertebral disc degeneration.
Gopal D; Ho AL; Shah A; Chi JH
Adv Exp Med Biol; 2012; 760():114-33. PubMed ID: 23281517
[TBL] [Abstract][Full Text] [Related]
50. In-vitro models of disc degeneration - A review of methods and clinical relevance.
Rivera Tapia ED; Meakin JR; Holsgrove TP
J Biomech; 2022 Sep; 142():111260. PubMed ID: 36027637
[TBL] [Abstract][Full Text] [Related]
51. Cartilage intermediate layer protein affects the progression of intervertebral disc degeneration by regulating the extracellular microenvironment (Review).
Liu L; He J; Liu C; Yang M; Fu J; Yi J; Ai X; Liu M; Zhuang Y; Zhang Y; Huang B; Li C; Zhou Y; Feng C
Int J Mol Med; 2021 Feb; 47(2):475-484. PubMed ID: 33416131
[TBL] [Abstract][Full Text] [Related]
52. Fibronectin splicing variants in human intervertebral disc and association with disc degeneration.
Anderson DG; Markova D; Adams SL; Pacifici M; An HS; Zhang Y
Spine (Phila Pa 1976); 2010 Aug; 35(17):1581-8. PubMed ID: 20628340
[TBL] [Abstract][Full Text] [Related]
53. Analysis of Extracellular ATP Distribution in the Intervertebral Disc.
Yin X; Vesvoranan O; Andreopoulos F; Dauer EA; Gu W; Huang CC
Ann Biomed Eng; 2024 Mar; 52(3):542-555. PubMed ID: 37934317
[TBL] [Abstract][Full Text] [Related]
54. Estrogen receptor expression in lumbar intervertebral disc of the elderly: gender- and degeneration degree-related variations.
Song XX; Yu YJ; Li XF; Liu ZD; Yu BW; Guo Z
Joint Bone Spine; 2014 May; 81(3):250-3. PubMed ID: 24838202
[TBL] [Abstract][Full Text] [Related]
55. The Proteolysis of ECM in Intervertebral Disc Degeneration.
Liang H; Luo R; Li G; Zhang W; Song Y; Yang C
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163637
[TBL] [Abstract][Full Text] [Related]
56. Current trends in biologics delivery to restore intervertebral disc anabolism.
Fontana G; See E; Pandit A
Adv Drug Deliv Rev; 2015 Apr; 84():146-58. PubMed ID: 25174310
[TBL] [Abstract][Full Text] [Related]
57. Migration of bone marrow-derived cells for endogenous repair in a new tail-looping disc degeneration model in the mouse: a pilot study.
Sakai D; Nishimura K; Tanaka M; Nakajima D; Grad S; Alini M; Kawada H; Ando K; Mochida J
Spine J; 2015 Jun; 15(6):1356-65. PubMed ID: 25459743
[TBL] [Abstract][Full Text] [Related]
58. Engineered Human Intervertebral Disc Model Inducing Degenerative Microglial Proinflammation.
Hwang MH; Kang YJ; Son HG; Cho H; Choi H
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293070
[TBL] [Abstract][Full Text] [Related]
59. [Research progress of Wnt/beta-catenin and nuclear factor-kappa B pathways and their relevance to intervertebral disc degeneration].
Kong J; Ma X; Wang T; Ma J; Tian P; Han C; Zang J; Li P; Jiang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1523-8. PubMed ID: 24640378
[TBL] [Abstract][Full Text] [Related]
60. Papain-induced in vitro disc degeneration model for the study of injectable nucleus pulposus therapy.
Chan SC; Bürki A; Bonél HM; Benneker LM; Gantenbein-Ritter B
Spine J; 2013 Mar; 13(3):273-83. PubMed ID: 23353003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
